JO
PTX

John Overdeck’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

John Overdeck’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,729
Closed -$1.79M – 3292
2015
Q1 		$1.79M Buy
+16,729
New +$1.59M 0.01% 1237
2014
Q3 		– Sell
-5,689
Closed -$511K – 2283
2014
Q2 		$511K Buy
+5,689
New +$349K ﹤0.01% 1596

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

John Overdeck's PTX Position: Q2 2015 in Review

John Overdeck sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2015, closing a stake of 16,729 shares — an estimated $1.79M sold.

John Overdeck first reported a position in PTX in Q2 2014 and held it in 2 quarters. The position peaked at $1.79M in Q1 2015. 114 funds tracked by Wall St. Rank hold PTX as of Q2 2015.

  • John Overdeck reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2015 after selling out during the quarter.
  • John Overdeck sold 16,729 Pernix Therapeutics Holdings, Inc. shares in Q2 2015, an estimated $1.79M.
  • John Overdeck first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 2 quarters.
  • John Overdeck's Pernix Therapeutics Holdings, Inc. position peaked at $1.79M in Q1 2015.
  • 114 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2015.

Based on Two Sigma Investments's 13F filing for Q2 2015, filed 14 Aug 2015.